Sorrento Therapeutics Inc (SRNE): A casual analysis of the recent Motley F...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	2
Posts	46
Boards Moderated	0
Alias Born	02/18/2013

PHAN

Re: None

Saturday, 02/13/2021 2:16:59 PM

Saturday, February 13, 2021 2:16:59 PM

A casual analysis of the recent Motley Fool hit piece is fascinating to say the least. The "DR." is not even a medical doctor but a PHD in Biology and a stated financial advisor. The MF disclosure policy only requires him to verify stock ownership on companies he is reporting on. In this case he does not have to disclose his ownership in Sorrento's competitors which you can see on his required listing page. One of those companies has an IH message board that was dormant for 5 years until Blackrock Inc. bought 10 million shares last week, a 16% ownership. So many cooks stirring this pot.

https://www.fool.com/investing/2021/02/12/sorrento-therapeutics-reports-promising-data-from/

Keep Last Read

Replies (2) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SRNE News

Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM